Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 676–700 of 7,816 matching trials · page 28 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept Study NCT07673770 EEG-triggered TMS Runs in: Canada · 1 site |
NA other |
RECRUITING | 30 | McMaster University OTHER |
2026-07-07 |
|
Smartphone App for Adolescents With Idiopathic Scoliosis NCT07686848 DinSkoliose smartphone application Runs in: Norway · 1 site |
NA other |
NOT_YET_RECRUITING | 30 | Oslo Metropolitan University OTHER |
2026-07-07 |
|
The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment NCT07688382 aromatherapy |
NA other |
NOT_YET_RECRUITING | 70 | China Medical University, China OTHER |
2026-07-07 |
|
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers NCT07688460 Lecanemab Runs in: China · 1 site |
PHASE4 anti-amyloid-antibody |
RECRUITING | 100 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine OTHER |
2026-07-07 |
|
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease NCT04576793 11C-ER176; 18F-MK6240; 18F-Florbetaben; Lumbar Puncture Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 100 | Columbia University OTHER |
2026-07-06 |
|
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease NCT05138848 Time in Bed Restriction; Sleep Schedule Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 99 | University of Pittsburgh OTHER |
2026-07-06 |
|
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology NCT05184569 Verdiperstat Runs in: United States · 5 sites |
PHASE1 other |
ACTIVE_NOT_RECRUITING | 64 | Peter Ljubenkov, MD OTHER |
2026-07-06 |
|
The Brain Health Study: A Pragmatic, Patient-Centered Trial NCT05356702 Brain Health Assessment Runs in: United States · 5 sites |
NA other |
COMPLETED | 3,417 | Kaiser Permanente OTHER |
2026-07-06 |
|
Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment NCT05858008 Time-restricted eating Runs in: United States · 1 site |
NA other |
RECRUITING | 15 | Julie Pendergast OTHER |
2026-07-06 |
|
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) NCT05980949 KarXT Runs in: Argentina; Belgium; Brazil; Bulgaria; Canada; Chile; Chin... · 429 sites |
PHASE3 other |
RECRUITING | 1,000 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company INDUSTRY |
2026-07-06 |
|
The Care for America's Aging Study NCT06021704 Enhanced home health aide training in dementia and dementia-related... Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 120 | Massachusetts General Hospital OTHER |
2026-07-06 |
|
Online Interplay Between Deciding and Acting With Mild Cognitive Impairment NCT06493422 Reaching Movements Runs in: United States · 1 site |
NA other |
COMPLETED | 41 | University of Delaware OTHER |
2026-07-06 |
|
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia NCT07033481 Neflamapimod; Placebo Runs in: United Kingdom; United States · 7 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 20 | EIP Pharma Inc INDUSTRY |
2026-07-06 |
|
Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training NCT07445841 Multimodal Training; Balance, Toning and Stretching Runs in: Canada · 2 sites |
NA other |
RECRUITING | 120 | McGill University OTHER |
2026-07-06 |
|
LifeBio Memory: Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement NCT07685067 LifeBio Memory (LBM) digital reminiscence intervention |
NA other |
NOT_YET_RECRUITING | 168 | George Mason University OTHER |
2026-07-06 |
|
Stimulation to Improve Memory NCT03875326 1 mA HD-tDCS; 2 mA HD-tDCS; 3 mA HD-tDCS; Sham Runs in: United States · 1 site |
NA other |
COMPLETED | 233 | University of Michigan OTHER |
2026-07-02 |
|
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease NCT06189963 SNK01; Placebo Runs in: Canada; United States · 8 sites |
PHASE1|PHASE2 other |
RECRUITING | 36 | NKGen Biotech, Inc. INDUSTRY |
2026-07-02 |
|
Autophagy-Enhancers to Reduce Sleep Disturbances NCT07383311 Spermidine Supplementation; Dietary Placebo Runs in: Germany · 1 site |
NA other |
RECRUITING | 76 | University Medicine Greifswald OTHER |
2026-07-02 |
|
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes? NCT07546409 Ketone Monoester (KE); Placebo Runs in: United States · 2 sites |
NA other |
RECRUITING | 20 | University of Alabama at Birmingham OTHER |
2026-07-02 |
|
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease NCT07680335 Plasma p-tau217 and neurofilament light chain results Runs in: Netherlands · 8 sites |
NA other |
RECRUITING | 550 | Alzheimercentrum Amsterdam OTHER |
2026-07-02 |
|
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood NCT07681401 Financial Counseling and Advocacy Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | University of Utah OTHER |
2026-07-02 |
|
Sirtuin-NAD Activator in Alzheimer's Disease NCT05040321 MIB-626; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 22 | Brigham and Women's Hospital OTHER |
2026-07-01 |
|
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study NCT05809908 Tricaprilin; Placebo |
PHASE3 other |
NOT_YET_RECRUITING | 535 | Cerecin INDUSTRY |
2026-07-01 |
|
A Scalable Nutrition Adherence Intervention NCT06121986 Improving Cognitive Aging through Nutrition (ICAN) Adherence Progra... Runs in: United States · 1 site |
NA other |
COMPLETED | 61 | Florida State University OTHER |
2026-07-01 |
|
Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia NCT06273917 PRIDE Runs in: United States · 3 sites |
NA other |
COMPLETED | 300 | National Institute on Aging (NIA) NIH |
2026-07-01 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial